Skip to content
10-Q

Quarterly Report

Yew Bio-Pharm Group, Inc.

0001493152-21-020137

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 13, 2021 51.7M sh
Shares Diluted Q2 2021 · Jun 30, 2021 51.7M sh
Shares Diluted Q2 2021 · Jun 30, 2021 51.7M sh
Shares Diluted Q2 2021 · Jun 30, 2020 51.7M sh
Shares Diluted Q2 2021 · Jun 30, 2020 51.7M sh
Capex Q2 2021 · Jun 30, 2021 $58.37K
Capex Q2 2021 · Jun 30, 2020 $39.35K
Operating Cash Flow Q2 2021 · Jun 30, 2021 $1.04M
Operating Cash Flow restated Q2 2021 · Jun 30, 2020 $7.04M
Short Term Debt Q2 2021 · Jun 30, 2021 $9.28M
Short Term Debt Q2 2021 · Dec 31, 2020 $8.98M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $166.93K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $563.79K
Stockholders Equity Q2 2021 · Jun 30, 2021 $48.33M
Stockholders Equity Q2 2021 · Dec 31, 2020 $45.48M
Current Liabilities Q2 2021 · Jun 30, 2021 $13.5M
Current Liabilities Q2 2021 · Dec 31, 2020 $10.53M
Total Liabilities Q2 2021 · Jun 30, 2021 $14.94M
Total Liabilities Q2 2021 · Dec 31, 2020 $12.96M
Current Assets Q2 2021 · Jun 30, 2021 $20.52M
Current Assets Q2 2021 · Dec 31, 2020 $9.99M
Total Assets Q2 2021 · Jun 30, 2021 $63.25M
Total Assets Q2 2021 · Dec 31, 2020 $58.45M
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.01
Eps Diluted Q2 2021 · Jun 30, 2021 $0.05
Eps Diluted Q2 2021 · Jun 30, 2020 $0.01
Eps Diluted Q2 2021 · Jun 30, 2020 $0.02
Eps Basic Q2 2021 · Jun 30, 2021 −$0.01
Eps Basic Q2 2021 · Jun 30, 2021 $0.05
Eps Basic Q2 2021 · Jun 30, 2020 $0.01
Eps Basic Q2 2021 · Jun 30, 2020 $0.02
Sga Expense Q2 2021 · Jun 30, 2021 $208.29K
Sga Expense Q2 2021 · Jun 30, 2021 $482.06K
Sga Expense Q2 2021 · Jun 30, 2020 $235.42K
Sga Expense Q2 2021 · Jun 30, 2020 $516.94K
Net Income Q2 2021 · Jun 30, 2021 −$544.78K
Net Income Q2 2021 · Jun 30, 2021 $2.37M
Net Income Q2 2021 · Jun 30, 2020 $737.57K
Net Income Q2 2021 · Jun 30, 2020 $888.98K
Operating Income Q2 2021 · Jun 30, 2021 −$430.64K
Operating Income Q2 2021 · Jun 30, 2021 $2.54M
Operating Income Q2 2021 · Jun 30, 2020 $856.5K
Operating Income Q2 2021 · Jun 30, 2020 $1.01M
Gross Profit Q2 2021 · Jun 30, 2021 −$228.03K
Gross Profit Q2 2021 · Jun 30, 2021 $728.95K
Gross Profit Q2 2021 · Jun 30, 2020 $1.29M
Gross Profit Q2 2021 · Jun 30, 2020 $1.73M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $15.07M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $22.85M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $8.28M
Cost Of Revenue Q2 2021 · Jun 30, 2020 $9.86M
Revenue Q2 2021 · Jun 30, 2021 $14.84M
Revenue Q2 2021 · Jun 30, 2021 $23.58M
Revenue Q2 2021 · Jun 30, 2020 $9.56M
Revenue Q2 2021 · Jun 30, 2020 $11.59M